Berkeley Lights, Inc. BLI
1.20 0.00 (+0.00%)
At closeMar 21, 2023, 4:00 PM EDT
1.15 Day range 1.30
52-week range unavailable
- Market cap
- 86.61M
- Revenue (ttm)
- 78.59M
- Profit margin
- -124.74%
- Shares out
- 72.17M
- Forward P/E
- -1.28
- Volume
- 2.29M
- Open
- 1.28
- Previous close
- 1.20
- Day's range
- 1.15 – 1.30
- Beta
- 1.36
- Analysts
- Hold
- Price target
- 7.50 (+525.0%)
- Earnings date
- May 8, 2023
No chart data for this range yet.
Key statistics
- Enterprise value
- 1.12M
- PEG ratio
- 0.00
- Price / sales
- 1.10
- Price / book
- 0.61
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -23.10%
- Free cash flow
- -17.70M
- Total cash
- 132.77M
- Total debt
- 45.84M
- Return on equity
- -55.98%
- Short % of float
- 5.45%
- 50-day average
- 1.65
- 200-day average
- 2.96
Analyst view
Consensus: hold
Hold
Price target (mean) 7.50 +525.0% upside
Now 1.20
- Target (low)
- 5.00
- Target (mean)
- 7.50
- Target (high)
- 10.00
Ratings (-1m) 7 2 buy · 4 hold · 1 sell
- Strong buy0
- Buy2
- Hold4
- Sell1
- Strong sell0
Next earnings
May 8, 2023
Expected May 8, 2023. Consensus EPS estimate -0.28.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| May 8, 2023 | Mar 1, 2023 | -0.27 | — | — | — |
| Feb 23, 2023 | Dec 1, 2022 | -0.24 | — | — | — |
| Nov 8, 2022 | Sep 1, 2022 | -0.27 | — | — | — |
| Aug 9, 2022 | Jun 1, 2022 | -0.30 | — | — | — |
| May 9, 2022 | Mar 1, 2022 | -0.31 | — | — | — |
| Feb 24, 2022 | Dec 1, 2021 | -0.25 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 10, 2022 | Morgan Stanley | down | Equal-Weight | Underweight |
| Aug 10, 2022 | BTIG | down | Buy | Neutral |
| Aug 10, 2022 | JP Morgan | down | Overweight | Neutral |
| May 10, 2022 | Morgan Stanley | main | — | Equal-Weight |
| Feb 25, 2022 | Morgan Stanley | main | — | Equal-Weight |
| Feb 15, 2022 | Morgan Stanley | main | — | Equal-Weight |
About Berkeley Lights, Inc.
Berkeley Lights, Inc., a cell biology company, operates in enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products in North America, the Asia Pacific, and Europe. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. Berkeley Lights, Inc. was incorporated in 2011 and is headquartered in Emeryville, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- berkeleylights.com
News
Stocks That Hit 52-Week Lows On Tuesday 
Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company - Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Tuesday 
Stocks That Hit 52-Week Lows On Friday 
Berkeley Lights, Inc. (BLI) Q4 2022 Earnings Call Transcript 
Berkeley Lights Reports Fourth Quarter and Full Year 2022 Financial Results 
Earnings Scheduled For February 23, 2023 
ISOPLEXIS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IsoPlexis Corporation - ISO 
Berkeley Lights to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
Your note
Sign in to keep a note on BLI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BREINLINGER KEITH J. | Chief Technology Officer | Conversion of Exercise of derivative security | Sep 15, 2022 | 157,442 |
| CHAPLIN SCOTT DAVID | Officer | Stock Award(Grant) | Sep 18, 2022 | 227,963 |
| JOSHI MEHUL | Chief Financial Officer | Stock Award(Grant) | Mar 2, 2023 | 516,942 |
| KADIA SIDDHARTHA | Chief Executive Officer | Stock Award(Grant) | Mar 2, 2023 | 1,240,690 |
| KHANDROS IGOR Y | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | May 25, 2022 | 9,005,860 |
| LUCIER GREGORY T | Director | Stock Award(Grant) | May 25, 2022 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 6.44% | 4,644,829 | 5.57M | Dec 30, 2022 |
| Mackenzie Financial Corporation | 5.78% | 4,168,601 | 5.00M | Dec 30, 2022 |
| Vanguard Group, Inc. (The) | 4.45% | 3,208,543 | 3.85M | Dec 30, 2022 |
| Nierenberg Investment Management Company, Inc. | 4.37% | 3,157,172 | 3.79M | Dec 30, 2022 |
| ARK Investment Management, LLC | 3.83% | 2,762,114 | 3.31M | Dec 30, 2022 |
| Glenview Capital Management, Llc | 3.62% | 2,610,677 | 3.13M | Dec 30, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ARK ETF Tr-ARK Genomic Revolution ETF | 3.79% | 2,737,064 | 3.28M | Dec 30, 2022 |
| Vanguard Total Stock Market Index Fund | 2.56% | 1,844,363 | 2.21M | Sep 29, 2022 |
| iShares Russell 2000 ETF | 1.74% | 1,253,620 | 1.50M | Dec 30, 2022 |
| Federated Hermes MDT Small Cap Core Fund | 1.68% | 1,209,524 | 1.45M | Oct 30, 2022 |
| Vanguard Extended Market Index Fund | 1.30% | 935,234 | 1.12M | Sep 29, 2022 |
| Federated Hermes MDT Mid Cap Growth Fund | 1.24% | 896,426 | 1.08M | Oct 30, 2022 |